Galectin Therapeutics reported $-0.2 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Galectin Therapeutics USD -0.2 0.01 Jun/2024
Gilead Sciences USD 2.55 9.3 Sep/2026
Immunic USD -0.1 0.03 Dec/2025
Incyte USD -3.6 6.69 Sep/2026
Merck USD 2.49 2.62 Sep/2026